PSNC Announcement: CEO Sue Sharpe will resign at end of 2017

PSNC Announcement: CEO Sue Sharpe will resign at end of 2017

May 9, 2017

PSNC Chief Executive Sue Sharpe has informed the committee that she intends to resign from her current position at the end of 2017.

Sue has held the role at PSNC since 2001.

Sue made the announcement at the May meeting of PSNC, which is being held in London.

Sue commented: 

“When I decided to inform PSNC of my decision to resign at the end of the year I was confident that by now we would have learnt the outcome of the Judicial Review, but we are still waiting.

The last 18 months have been very tough for the sector and for PSNC, and the challenges are not going away. Whatever the outcome of the case, we will need to continue to fight to ensure that pharmacies’ support for patients and role in our communities is protected and developed.

That remains PSNC’s priority and we are preparing the next stages in our campaign. All of my brilliant team are working and will continue to work to ensure the organisation does the very best for the contractors we represent.”

PSNC Chair Mike Pitt said:

“It has been a pleasure to work with Sue and the team at PSNC since I was appointed as Chair two years ago. Sue has been an exceptional advocate for community pharmacy, working tirelessly to promote the sector on behalf of PSNC and all the contractors it represents. She will be a very hard act to follow.

PSNC has already begun to consider the recruitment process for a replacement CEO, but it will of course take time to ensure that we appoint the right person.”



Posted in:


More Latest News >

Health & Care Review

Keeping up with all the latest developments in health and care policy could almost be a full time job and...

Ask PSNC: NUMSAS FAQs

The team at PSNC has received a number of queries on the NHS Urgent Medicine Supply Advanced Service (NUMSAS) since...

May 2017 Price Concessions/NCSO

The Department of Health has granted the following price concessions for May 2017: Drug Pack size Price concession Buspirone 10mg tablets...